Prebiotic galactooligosaccharides interact with mouse gut microbiota to attenuate acute graft-versus-host disease
Open Access
- 24 November 2022
- journal article
- letter
- Published by American Society of Hematology in Blood
- Vol. 140 (21) , 2300-2304
Abstract
Previous studies suggest that gut microbiome disruption induced by chemotherapy, dietary deficiencies, and/or antibiotics are associated with increased incidence of acute graft-versus-host disease (aGVHD) following hematopoietic stem cell transplantation (HSCT). In a murine model of antibiotic-induced gut microbiome disruption, Holmes and colleagues show that oral administration of galactooligosaccharides (GOS) as a prebiotic attenuates lethal aGVHD, highlighting the crosstalk between diet and gut microbiota. Their data encourage clinical trials of GOS prebiotic diets during HSCT.Keywords
This publication has 23 references indexed in Scilit:
- Associations between acute gastrointestinal GvHD and the baseline gut microbiota of allogeneic hematopoietic stem cell transplant recipients and donorsBone Marrow Transplantation, 2017
- Genomic characterization of the uncultured Bacteroidales family S24-7 inhabiting the guts of homeothermic animalsMicrobiome, 2016
- Gut microbiome–derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host diseaseNature Immunology, 2016
- Influence of galacto-oligosaccharide mixture (B-GOS) on gut microbiota, immune parameters and metabonomics in elderly personsBritish Journal of Nutrition, 2015
- The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantationBlood, 2014
- Metagenomic Analysis of the Stool Microbiome in Patients Receiving Allogeneic Stem Cell Transplantation: Loss of Diversity Is Associated with Use of Systemic Antibiotics and More Pronounced in Gastrointestinal Graft-versus-Host DiseaseTransplantation and Cellular Therapy, 2014
- Matched unrelated or matched sibling donors result in comparable outcomes after non-myeloablative HSCT in patients with AML or MDSBone Marrow Transplantation, 2013
- Risk factors for acute GVHD and survival after hematopoietic cell transplantationBlood, 2012
- Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponseBlood, 2006
- Target Antigens Determine Graft-versus-Host Disease PhenotypeThe Journal of Immunology, 2004